ABT vs GEHC
Abbott Laboratories (ABT) and GE HealthCare (GEHC) compared side by side. Abbott Laboratories (ABT) is larger, with a market cap of $179.4B versus $32.3B for GE HealthCare, about 5.6 times the size. On trailing earnings, GEHC is cheaper at 16.4x versus 38.6x for ABT.
Head to head
| Metric | ABT | GEHC |
|---|---|---|
| Market cap | $179.4B | $32.3B |
| P/E (TTM) | 38.6x | 16.4x |
| Forward P/E | 17.4x | 13.2x |
| Revenue (TTM) | $48.2B | $21.3B |
| Revenue growth | 14.5% | 5.8% |
| Gross margin | 57.1% | 39.5% |
| Operating margin | 11.3% | 15.0% |
| Free cash flow | $7.4B | $1.6B |
| Dividend yield | 2.43% | 0.22% |
| 1-year return | -15.9% | -7.3% |
| 5-year return (annual) | -2.0% | — |
| Max drawdown | -46% | -37% |
| FI Handbook grade | C+ | C |
Highlighted: the stronger figure on metrics where higher or lower is clearly better.
Growth of $10,000 (5 years, price only)
ABT vs GEHC FAQ
Which is bigger, ABT or GEHC?
Abbott Laboratories (ABT) is larger, with a market cap of $179.4B versus $32.3B for GE HealthCare, about 5.6 times the size.
Is ABT or GEHC cheaper?
On trailing earnings, GEHC is cheaper at 16.4x versus 38.6x for ABT. A lower P/E can reflect slower expected growth, so compare growth and margins too.
Which stock performed better over the past year, ABT or GEHC?
GEHC returned -7.3% over the past year including dividends, versus -15.9% for ABT, through October 23, 2026.
Which pays a higher dividend, ABT or GEHC?
ABT yields 2.43% versus 0.22% for GEHC.
Full pages: Abbott Laboratories · GE HealthCare